Latest & greatest articles for HIV Test

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on HIV Test or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on HIV Test and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for HIV Test

101. Gay Men's Attitudes and Perceptions Regarding Rapid HIV Home Testing

Gay Men's Attitudes and Perceptions Regarding Rapid HIV Home Testing Rapid Review #69: June 2013 Gay Men’s Attitudes and Perceptions Regarding Rapid HIV Home Testing Question What are gay men’s attitudes and perceptions regarding rapid HIV home testing? Key Take-Home Messages Rapid HIV home testing could be an effective risk reduction and HIV prevention tool (1). ? A majority of gay men are interested in accessing home testing (2-7). ? Gay men and other men who have sex with men (MSM) cite (...) reasons of convenience, accessibility, rapidity of results, and increased privacy, discretion, confidentiality and anonymity to underscore their interest in accessing rapid HIV home testing (3;5). ? Main concerns raised about the availability of rapid HIV home testing are: lack of professional support immediately at hand in the event of a positive test result (3), perceived uncertainty about its accuracy (7), incongruence with a sexual situation (8), and associated costs (8). ? Factors associated

2013 Ontario HIV Treatment Network

102. Effectiveness of HIV Testing Interventions for High-Risk Populations

Effectiveness of HIV Testing Interventions for High-Risk Populations Rapid Review #71: September 2013 Effectiveness of HIV Testing Interventions for High-Risk Populations Question Which HIV testing interventions have been shown to be effective for high-risk populations? Key Take-Home Messages ? People infected with HIV who are unaware of their HIV status may be driving the epidemic in high-risk populations.(1) Interventions that promote the uptake of HIV testing among men who have sex with men (...) and members of other groups at high risk have the potential to increase early diagnoses, thereby getting people into care sooner and reducing the likelihood of onward transmission.(1;2) ? HIV testing coverage is often inadequate in populations at high risk and varies widely across jurisdictions.(3) People at risk often do not comply with testing guidelines and recommendations.(4) ? A few HIV testing interventions have been shown to increase testing uptake (1;2;5-11), resulting in high seropositivity rates

2013 Ontario HIV Treatment Network

103. HIV and adolescents: Guidance for HIV testing and counselling and care for adolescents living with HIV

HIV and adolescents: Guidance for HIV testing and counselling and care for adolescents living with HIV RECOMMENDATIONS FOR A PUBLIC HEALTH APPROACH AND CONSIDERATIONS FOR POLICY-MAKERS AND MANAGERS HIV AND ADOLESCENTS: GUIDANCE FOR HIV TESTING AND COUNSELLING AND CARE FOR ADOLESCENTS LIVING WITH HIV United Nations Educational, Scienti?c and Cultural Organization ISBN 978 92 4 150616 8 HIV AND ADOLESCENTS: GUIDANCE FOR HIV TESTING AND COUNSELLING AND CARE FOR ADOLESCENTS LIVING WITH HIV ? World (...) Health Organization 20, avenue Appia CH–1211 Geneva 27 Switzerland For more information, contact: ? Department of HIV/AIDS E-mail: hiv-aids@who.int http://www.who.int/hiv/en/ ? Department of Maternal, Newborn, Child and Adolescent Health Email: mncah@who.int http://www.who.int/maternal_child_adolescent/en/RECOMMENDATIONS FOR A PUBLIC HEALTH APPROACH AND CONSIDERATIONS FOR POLICY-MAKERS AND MANAGERS HIV AND ADOLESCENTS: GUIDANCE FOR HIV TESTING AND COUNSELLING AND CARE FOR ADOLESCENTS LIVING

2013 World Health Organisation HIV Guidelines

104. Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial. Full Text available with Trip Pro

Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial. To increase human immunodeficiency virus (HIV) testing rates, many institutions and jurisdictions have revised policies to make the testing process rapid, simple, and routine. A major issue for testing scale-up efforts is the effectiveness of HIV risk-reduction counseling, which has historically been an integral part of the HIV testing process.To (...) assess the effect of brief patient-centered risk-reduction counseling at the time of a rapid HIV test on the subsequent acquisition of sexually transmitted infections (STIs).From April to December 2010, Project AWARE randomized 5012 patients from 9 sexually transmitted disease (STD) clinics in the United States to receive either brief patient-centered HIV risk-reduction counseling with a rapid HIV test or the rapid HIV test with information only. Participants were assessed for multiple STIs at both

2013 JAMA Controlled trial quality: uncertain

105. Provision of rapid HIV tests within a health service and frequency of HIV testing among men who have sex with men: randomised controlled trial. Full Text available with Trip Pro

Provision of rapid HIV tests within a health service and frequency of HIV testing among men who have sex with men: randomised controlled trial. To determine if the provision of rapid HIV testing to men who have sex with men attending a health service would increase their frequency of HIV testing over time.Non-blinded randomised controlled trial.Public sexual health service in Australia.Men who reported having a male sexual partner within the previous year and an HIV test within the previous two (...) years. Of 400 men entered, 370 (92.5%) completed the study.Men attending the service between September 2010 and March 2011 were randomised 1:1 to either ongoing access to rapid HIV testing obtained with finger prick or to conventional HIV serology with venepuncture, over 18 months.The incidence of all HIV testing after enrolment, including testing outside the study clinic, analysed by intention to treat.Of 200 men randomised to the rapid testing arm, 196 were followed for 288 person years. Of 200

2013 BMJ Controlled trial quality: predicted high

106. Effect of home based HIV counselling and testing intervention in rural South Africa: cluster randomised trial. Full Text available with Trip Pro

Effect of home based HIV counselling and testing intervention in rural South Africa: cluster randomised trial. To assess the effect of home based HIV counselling and testing on the prevalence of HIV testing and reported behavioural changes in a rural subdistrict of South Africa.Cluster randomised controlled trial.16 communities (clusters) in uMzimkhulu subdistrict, KwaZulu-Natal province, South Africa.4154 people aged 14 years or more who participated in a community survey.Lay counsellors (...) conducted door to door outreach and offered home based HIV counselling and testing to all consenting adults and adolescents aged 14-17 years with guardian consent. Control clusters received standard care, which consisted of HIV counselling and testing services at local clinics.Primary outcome measure was prevalence of testing for HIV. Other outcomes were HIV awareness, stigma, sexual behaviour, vulnerability to violence, and access to care.Overall, 69% of participants in the home based HIV counselling

2013 BMJ Controlled trial quality: predicted high

107. Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients Full Text available with Trip Pro

Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients Lack of point-of-care tests for tuberculosis (TB) result in diagnostic delay, and increased mortality and healthcare-related costs. The urine Determine(TM) TB-LAM point-of-care strip-test was evaluated in 335 prospectively-recruited hospitalised patients with suspected TB-HIV co-infection (group 1) and from 88 HIV-infected hospitalised patients with non-TB diagnoses (group 2). Cut (...) in 71% of Mycobacterium tuberculosis culture-positive patients. This preliminary study indicates that the LAM strip-test may be a potentially useful rapid rule-in test for TB in hospitalised patients with advanced immunosuppression. The grade 2, but not the manufacturer-recommended grade 1 cut-off point, offered superior rule-in utility and inter-reader reliability. Larger studies to evaluate cut-off points and diagnostic accuracy are urgently required.

2012 EvidenceUpdates

108. Home HIV Testing: Good News but Not a Game Changer Full Text available with Trip Pro

Home HIV Testing: Good News but Not a Game Changer 23044643 2013 01 28 2018 11 13 1539-3704 157 10 2012 Nov 20 Annals of internal medicine Ann. Intern. Med. Home HIV testing: good news but not a game changer. 744-6 Paltiel A David AD Yale School of Public Health, 60 College Street, Room 305, New Haven, CT 06520-8034, USA. david.paltiel@yale.edu Walensky Rochelle P RP eng R37 AI042006 AI NIAID NIH HHS United States R01 MH065869 MH NIMH NIH HHS United States R37 AI42006 AI NIAID NIH HHS United (...) States P30 AI060354 AI NIAID NIH HHS United States R01 DA015612 DA NIDA NIH HHS United States R01 MH65869 MH NIMH NIH HHS United States Journal Article Research Support, N.I.H., Extramural United States Ann Intern Med 0372351 0003-4819 0 Reagent Kits, Diagnostic AIM IM Diagnostic Test Approval HIV Infections diagnosis HIV-1 HIV-2 Health Services Humans Mass Screening Reagent Kits, Diagnostic Risk Factors Sexual Behavior 2012 10 10 6 0 2012 10 10 6 0 2013 1 29 6 0 ppublish 23044643 1377315 10.7326

2012 Annals of Internal Medicine

109. Universal voluntary HIV testing in antenatal care settings: a review of the contribution of provider-initiated testing and counselling Full Text available with Trip Pro

Universal voluntary HIV testing in antenatal care settings: a review of the contribution of provider-initiated testing and counselling Universal voluntary HIV testing in antenatal care settings: a review of the contribution of provider-initiated testing and counselling Universal voluntary HIV testing in antenatal care settings: a review of the contribution of provider-initiated testing and counselling Hensen B, Baggaley R, Wong VJ, Grabbe KL, Shaffer N, Lo YR, Hargreaves J CRD summary (...) This review found that provider-initiated testing and counselling in antenatal clinics could help achieve universal voluntary HIV testing of pregnant women. Due to some problems with the conduct of the review and the unclear quality of the evidence, this conclusion should be considered with caution. Authors' objectives To assess the contribution of provider-initiated testing and counselling in achieving universal HIV testing for pregnant women and to assess whether this model adheres to good practice

2012 DARE.

110. Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis (Abstract)

Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis To compare performance of testing for human immunodeficiency virus (HIV)-1 DNA and HIV-1 RNA for diagnosis of HIV-1 infection in infants receiving preventive antiretroviral therapy.This substudy of the French multicenter prospective cohort of neonates born to HIV-infected mothers, included 1567 infants tested for HIV with polymerase chain reaction (PCR) in a single (...) ) at birth and 1 month and 100% at 3 and 6 months. Type of maternal and neonatal prophylaxis had no effect on sensitivity, but influenced viral load.The performances of testing for HIV-1 DNA and RNA were similar with 100% sensitivity at 3 months. At 1 month during prophylaxis, 11% of infected children had negative PCR results.Copyright © 2012 Mosby, Inc. All rights reserved.

2012 EvidenceUpdates

111. Emergency department HIV screening with rapid tests: a cost comparison of alternative models Full Text available with Trip Pro

Emergency department HIV screening with rapid tests: a cost comparison of alternative models Emergency department HIV screening with rapid tests: a cost comparison of alternative models Emergency department HIV screening with rapid tests: a cost comparison of alternative models Hutchinson AB, Farnham PG, Lyss SB, White DA, Sansom SL, Branson BM Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of three strategies for HIV screening, using an opt-out rapid HIV test, in the emergency department; existing staff, supplemental staff, and a combination of these. The authors concluded that the combined strategy was more cost-effective than either the existing or the supplemental staff strategy

2012 NHS Economic Evaluation Database.

112. Towards universal voluntary HIV testing and counselling: a systematic review of community-based approaches

Towards universal voluntary HIV testing and counselling: a systematic review of community-based approaches Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation (...) -Bonferroni correction for testing multiple subgroup analyses will be performed. If one or more subgroup analyses cannot be performed due to insufficient data, the p-value will be adjusted accordingly. ">Other Subgroup analysis or meta-regression are used to explore between-study heterogeneity and can provide insight into the relationship between study characteristics (e.g. species, sex or drug class or dose) and effect size. They should be considered hypothesis-generating. Ideally, a threshold describing

2012 PROSPERO

113. Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc

Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc 1 Public Summary Document Application No. 1174 -Assessment of viral tropism testing of HIV to inform treatment with maraviroc Applicant: ViiV Healthcare Date of MSAC consideration: 29-30 November 2012 1. Purpose of application In May 2011, the Department of Health and Ageing received an application from ViiV Healthcare requesting a Medicare Benefits Schedule (MBS) listing for genotypic HIV (...) tropism for treatment with CCR5 antagonist maraviroc. This application was seeking genotypic HIV tropism testing to be funded through two avenues: 1. Through the creation of a new MBS item number to allow HIV tropism testing as part of the current genotype-assisted antiretroviral resistance testing (GART) suite of tests. 2. Through the creation of a new MBS item number for HIV tropism testing alone. This application was deemed to propose a co-dependent package of two types of health technology

2012 Medical Services Advisory Committee

114. Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc

Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc Medical Services Advisory Committee Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has (...) been made for the HTA database. Citation Medical Services Advisory Committee. Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc. Canberra: Medical Services Advisory Committee (MSAC). MSAC application 1174. 2012 Authors' conclusions After considering the strength of the available evidence in relation to the safety, clinical effectiveness and cost-effectiveness of genotypic testing for HIV tropism to help determine eligibility for existing PBS

2012 Health Technology Assessment (HTA) Database.

115. Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples

Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples WHO | Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples WHO Regional websites Access HIV/AIDS Menu Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples Recommendations for a public health (...) approach Publication details Editors : WHO HIV/AIDS Programme Number of pages : 80 Publication date : April 2012 Languages : English ISBN : 978 92 4 150197 2 Downloads pdf, 727kb Overview New WHO guidelines recommend offering HIV testing and counselling to couples, wherever HIV testing and counselling is available, including in antenatal clinics. For couples where only one partner is HIV positive, the guidelines recommend offering antiretroviral therapy to the HIV positive partner, regardless of his

2012 World Health Organisation Guidelines

116. Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples

Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples For more information, contact: World Health Organization Department of HIV/AIDS 20, avenue Appia 1211 Geneva 27 Switzerland E-mail: hiv-aids@who.int http://www.who.int/hiv/en/ ISBN 978 92 4 1501972 hiv/aids Programme April 2012 GUIDANCE ON COUPLES HIV TESTING AND COUNSELLING INCLUDING ANTIRETROVIRAL THERAPY FOR TREATMENT AND PREVENTION IN SERODISCORDANT (...) COUPLES Recommendations for a public health approachhiv/aids Programme April 2012 GUIDANCE ON COUPLES HIV TESTING AND COUNSELLING INCLUDING ANTIRETROVIRAL THERAPY FOR TREATMENT AND PREVENTION IN SERODISCORDANT COUPLES Recommendations for a public health approachWHO Library Cataloguing-in-Publication Data Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach. 1.HIV infections

2012 World Health Organisation HIV Guidelines

117. Rapid HIV Testing in Correctional Facilities

Rapid HIV Testing in Correctional Facilities Rapid Review #60: August 2012 Rapid HIV Testing in Correctional Facilities Questions What is the potential need for rapid HIV testing in correctional facilities? What type of testing (opt-in, opt-out, voluntary, mandated, standard, rapid) does the literature suggest? What are the benefits of rapid HIV testing in these settings? Key Take-Home Messages ? HIV rates are particularly high in correctional settings. In the U.S., HIV prevalence is five times (...) higher in state and federal correctional systems than in the general population 1 . ? In Canada, HIV prevalence is also higher among persons in prison than in the general population. In 2006, 1.64% of people in Canadian federal prisons were reported to be HIV positive vs. 0.3% in the general adult population 2 . ? The Centers for Disease Control and Prevention (CDC) advocates for voluntary and routine testing in all correctional settings and suggests that testing be conducted through opt-out rather

2012 Ontario HIV Treatment Network

118. Return on public health investment: CDC's expanded HIV testing initiative Full Text available with Trip Pro

Return on public health investment: CDC's expanded HIV testing initiative Return on public health investment: CDC's expanded HIV testing initiative Return on public health investment: CDC's expanded HIV testing initiative Hutchinson AB, Farnham PG, Duffy N, Wolitski RJ, Sansom SL, Dooley SW, Cleveland JC, Mermin JH Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study examined the clinical/economic impact of a large-scale HIV testing programme – the Expanded HIV-Testing Initiative (EHTI) – for populations affected disproportionally by HIV. The economic evaluation was based on a financial return on investment (ROI) analysis. The authors concluded that the programme averted HIV infections and provided positive ROI

2012 NHS Economic Evaluation Database.

119. Factors influencing uptake of HIV testing and counselling in middle and low-income countries

Factors influencing uptake of HIV testing and counselling in middle and low-income countries Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address (...) models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one experimental group, we will correct the total number of control animals in the meta-analysis by dividing the number of animals in the control group by the number of treatment groups served. Where applicable, Holm-Bonferroni correction for testing multiple

2011 PROSPERO

120. HIV testing: increasing uptake in men who have sex with men

HIV testing: increasing uptake in men who have sex with men HIV testing: increasing uptake in men who have sex with men | Guidance | NICE HIV testing: increasing uptake in men who have sex with men Public health guideline [PH34] Published date: March 2011 Guidance This guidance has been updated and replaced by . Explore © NICE [year]. All rights reserved. Subject to .

2011 National Institute for Health and Clinical Excellence - Clinical Guidelines